Lv1
30 积分 2023-05-05 加入
PF-08046032: A novel, investigational CD25-directed antibody-drug conjugate optimized for selective depletion of regulatory T cells in advanced malignant tumors
1天前
已完结
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique
1个月前
已完结
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies
4个月前
已完结
CD6 triggers actomyosin cytoskeleton remodeling after binding to its receptor complex
4个月前
已完结
Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer
6个月前
已完结
520LBA (PB-520) LBA Posters: Preclinical characterization of LY4175408, a novel PTK7 targeting antibody-drug conjugate, utilizing exatecan via a hydrophilic polysarcosine linker platform
6个月前
已完结
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
7个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
7个月前
已完结
CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer
9个月前
已完结
皖公网安备34019202002308
